Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer

Clinical trial NCT00428766 · COMPLETED

Trial details

NCT number: NCT00428766
Sponsor: Morphotek
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer

Start date: 2005-06-01
Primary completion: 2007-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.